Agilent Technologies, Inc. reported a net revenue of $1,738 million for the three months ended July 31, 2025, marking a 10% increase from $1,578 million in the same period last year. For the nine months ended July 31, 2025, revenue rose 6% to $5,087 million compared to $4,809 million in the prior year. The growth was driven by all segments and geographic regions, with a notable contribution of approximately 2 percentage points from the BIOVECTRA acquisition. Net income for the quarter was $336 million, up from $282 million a year earlier, while for the nine months, it decreased to $869 million from $938 million.
The company experienced significant changes in its operational structure, having reorganized its segments in November 2024 to enhance its market-focused strategy. The former Diagnostics and Genomics segment was merged with liquid chromatography platforms to form the Life Sciences and Diagnostics Markets segment. This restructuring aims to better align with customer needs and improve operational efficiency. The new segment structure has been reflected in the financial statements since the beginning of 2025.
Operationally, Agilent's employee headcount increased to approximately 18,000 as of July 31, 2025, compared to 17,400 a year prior. The company reported a gross margin of 51.1% for the quarter, down from 54.2% in the previous year, attributed to higher tariffs, shipping costs, and unfavorable product mix. Research and development expenses decreased by 13% to $111 million for the quarter, while selling, general, and administrative expenses rose by 6% to $417 million.
Looking ahead, Agilent remains optimistic about its growth prospects despite ongoing challenges such as inflation and tariff impacts. The company plans to continue investing in research and development and expanding its product offerings, particularly in the life sciences and diagnostics markets. Management expects to mitigate the adverse effects of recent tariff changes in the upcoming fiscal year and is focused on enhancing customer experiences and operational efficiencies.
About AGILENT TECHNOLOGIES, INC.
Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, offering instruments, software, services, and consumables for laboratory workflows. With a focus on enhancing customer outcomes, Agilent targets pharmaceutical, biopharmaceutical, and academic sectors, addressing a $60 billion market opportunity. The company is innovating through advanced manufacturing partnerships and expanding its diagnostics and genomics capabilities, including cell analysis and companion diagnostics, to meet evolving healthcare needs.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.